# Canadian Journal of Kidney Health and Disease

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/canadian-journal-of-kidney-health-and-disease/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 1,800 |
| Citations | 11,356 |
| h-index | 46 |
| Homepage | https://us.sagepub.com/en-us/nam/canadian-journal-of-kidney-health-and-disease/journal202590 |
| Open Access | true |
| ISSN-L | 2054-3581 |
| ISSNs | 2054-3581 |
| OpenAlex ID | https://openalex.org/S2764509245 |
| Publisher | SAGE Publishing |
| Works | 953 |

## Journal papers

Showing 12 of 14.

- [Total Kidney Volume as a Biomarker of Disease Progression in Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/total-kidney-volume-as-a-biomarker-of-disease-progression-in-autosomal-dominant/)
- [Prescription Patterns in Dialysis Patients: Differences Between Hemodialysis and Peritoneal Dialysis Patients and Opportunities for Deprescription](https://scholariq.org/papers/prescription-patterns-in-dialysis-patients-differences-between-hemodialysis-and/)
- [Updated Canadian Expert Consensus on Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/updated-canadian-expert-consensus-on-assessing-risk-of-disease-progression-and/)
- [Development and Validation of Nine Deprescribing Algorithms for Patients on Hemodialysis to Decrease Polypharmacy](https://scholariq.org/papers/development-and-validation-of-nine-deprescribing-algorithms-for-patients-on/)
- [Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/assessing-risk-of-disease-progression-and-pharmacological-management-of/)
- [Mainstreaming Genetic Testing for Adult Patients With Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/mainstreaming-genetic-testing-for-adult-patients-with-autosomal-dominant/)
- [Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder](https://scholariq.org/papers/canadian-society-of-nephrology-commentary-on-the-kidney-disease-improving-global/)
- [Association of Serum Phosphate Derangement With Mortality in Patients on Continuous Renal Replacement Therapy](https://scholariq.org/papers/association-of-serum-phosphate-derangement-with-mortality-in-patients-on/)
- [Skin Staining Following Intravenous Iron Extravasation in a Patient With Chronic Kidney Disease: A Case Report](https://scholariq.org/papers/skin-staining-following-intravenous-iron-extravasation-in-a-patient-with-chronic/)
- [Development and Validation of Patient Education Tools for Deprescribing in Patients on Hemodialysis](https://scholariq.org/papers/development-and-validation-of-patient-education-tools-for-deprescribing-in/)
- [Outcomes of Patients With Autosomal Dominant Polycystic Kidney Disease Prescribed SGLT2 Inhibitors in British Columbia: A Single-Arm Retrospective Cohort Study](https://scholariq.org/papers/outcomes-of-patients-with-autosomal-dominant-polycystic-kidney-disease/)
- [Eight Years of Canadian Real-World Assessment of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease: The C-MAJOR Registry](https://scholariq.org/papers/eight-years-of-canadian-real-world-assessment-of-tolvaptan-in-patients-with/)

## Journal top topics

Showing 8 of 25.

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)
- [Organ Donation and Transplantation](https://scholariq.org/topics/organ-donation-and-transplantation/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Central Venous Catheters and Hemodialysis](https://scholariq.org/topics/central-venous-catheters-and-hemodialysis/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.